CNBX Pharmaceuticals's total assets for Q3 2026 were $12.79K, a decrease of -14.12% from the previous quarter. CNBX total liabilities were $2.67M for the fiscal quarter, a 4.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.